[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556996":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":35,"responsibleParty":54,"collaborators":56,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":64,"acronym":19,"eligibilityCriteria":65,"healthyVolunteers":62,"sex":66,"minAge":67,"maxAge":19,"enrollmentInfo":68,"targetDuration":19,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":19,"overallStatus":38,"whyStopped":19,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Queen's Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Contingency Managment","EXPERIMENTAL","Participants are allowed to complete CM three times per week for the maximum of 12-weeks. At the six- and 12-week time points, participants will complete the Treatment Effectiveness Assessment (TEA) with study personnel.",[13],"Behavioral: Contingency Managment",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"BEHAVIORAL","If the sample be methamphetamine negative, participant will be positively reinforced and offered incentives. Participants immediately draw the reinforcement slip of paper to receive a prize from a selection kept on-site. Approximately, half of the slips offer written praise (e.g. \"great job!\"). The other half of slips are then divided between low value (e.g. food gift cards, bus passes), medium value (e.g. prepaid cell phone, clothing gift cards), and a few large value rewards (e.g. iPad, jewelry). Should the sample be positive for methamphetamine, no reinforcement and\u002For incentive to be provided. Participant will be encouraged to continue to participate in CM program and follow-up on the next CM date.",[9],null,[21],{"name":22,"affiliation":23,"role":24},"Todd Seto, MD","The Queens Medical Center","STUDY_CHAIR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":19,"email":30},"Nicholas R Schumann, Clinical Psychologist","CONTACT","(808) 691-7024","nschumann@queens.org",{"name":32,"role":28,"phone":33,"phoneExt":19,"email":34},"Karen Ng, RN","808-691-4729","kng@queens.org",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"The Queen's Medical Center","RECRUITING","Honolulu","Hawaii","90813","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-157.85833,21.30694,{"lat":48,"lon":47},[51],{"name":52,"role":28,"phone":53,"phoneExt":19,"email":30},"Nicholas Schumann","8086917024",{"type":55,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR",[57],{"name":58,"class":59},"National Institute of General Medical Sciences (NIGMS)","NIH","100556996","implementing-a-contingency-management-program-addressing-methamphetamine-use-for-and-with-the-people-of-hawaii-100556996",false,"NCT06532370","Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii","Inclusion Criteria:\n\n* Admitted trauma patients\n* Age greater than 18 years old\n* Urine drug screen positive for methamphetamines during the current hospitalization\n* Report at least weekly methamphetamine use\n* First methamphetamine use greater than 6 months prior to injury\n* Report at least 4 DSM-V Amphetamine-Type Substance Use Disorder symptoms (at least moderate disease)\n* Glasgow Coma Scale ≥13 upon arrival to the emergency department\n* Ability to understand and participate in study procedures\n* Ability to communicate in English\n\nExclusion Criteria:\n\n* Active psychosis (reporting auditory or visual hallucinations)\n* Under ongoing cardiorespiratory monitoring\n* Evidence of moderate or severe traumatic brain injury\n* Patients who are known to be pregnant\n* Prisoner\n* Individuals incarcerated at the time of their hospitalization\n* Individuals lacking capacity to provide, or are otherwise unable or unwilling to provide written informed consent","ALL","18 Years",{"count":69,"type":70},40,"ESTIMATED","INTERVENTIONAL",[73],"NA","The goal of this clinical trial is to use contingency management (CM) as an intervention tool to address methamphetamine use.\n\nThe main objectives are to:\n\n* Gather effectiveness data on a pilot a CM program for participants in Hawaii who use methamphetamine following hospitalization due to traumatic injury\n* To assess participant perspectives on engaging with a CM program based at a Level 1 Trauma Center. Researches will assess both patient-reported and biologically-confirmed medium-term program effectiveness and conduct qualitative interviews with participants post-program.\n\nParticipants will:\n\n* Visit a follow-up clinic up to three times per week to complete urinalysis following discharge from the trauma unit\n* Complete Treatment Effectiveness Assessments at 6 and 12-weeks\n* Engage in a qualitative interview at the end of the CM program",[9,76],"Methamphetamine Use Disorder","2026-03-29",{"date":79,"type":80},"2026-03-31","ACTUAL",{"date":82,"type":80},"2024-10-10",{"date":84,"type":70},"2026-12-30",{"name":5,"class":6},1]